Paravertebral Block vs. Suprascapular Block for Treatment of Frozen Shoulder

Pain, Shoulder Clinical Trial

Official title:

Paravertebral Block Versus Suprascapular Block for Treatment of Frozen Shoulder: a Prospective, Randomized Clinical Trial

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04709874
• Other study ID #: 11012021
• Status: Recruiting
• Phase: N/A
• Start date: January 2, 2022
• Est. completion date: January 2023

Study information

• Verified date: January 2022
• Source: Makassed General Hospital
• Contact: Zoher Naja, MD
• Phone: +9611636000
• Email: zouhnaja[@]yahoo.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Background: Adhesive capsulitis, or frozen shoulder, is a major orthopedic condition that causes pain and functional limitation. Although different nonsurgical conservative therapies such as physical therapy, nonsteroidal anti-inflammatory drugs, and corticosteroid injections have been used, yet there is no standard treatment for frozen shoulder. Objectives: The primary objective of this study is to compare the effectiveness of nerve stimulator guided paravertebral block versus suprascapular block for treatment of frozen shoulder. The primary outcome is pain measured through the Visual Analogue Scale (VAS) over a follow up period of 6 months. Methods: This is a prospective randomized clinical trial that will be conducted between February 2021 and January 2022. Patients will be randomly allocated into two groups. Group I will receive paravertebral block guided by a nerve stimulator. Group II patients will receive suprascapular nerve block. Patients will be followed up at week 1, month 1, month 3 and month 6.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 50
• Est. completion date: January 2023
• Est. primary completion date: January 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• 18 years and older
• presenting with frozen shoulder and were unresponsive to conservative therapy

Exclusion Criteria:

• Complete rotator cuff tear
• Osteoarthritis
• Calcified tendinitis
• History of shoulder joint injury
• Cervical radiculopathy
• Bleeding disorder
• Active infection
• Allergy to Bupivacaine
• Diabetes Mellitus

Related Conditions & MeSH terms

• Bursitis
• Pain, Shoulder
• Shoulder Pain

Intervention

Other:
• Paravertebral block
Paravertebral block using nerve stimulator guidance will be done at C7-T1
• Suprascapular block
Paravertebral block using nerve stimulator guidance will be done

Locations

Country	Name	City	State
Lebanon	Makassed General Hospital	Beirut

Sponsors (1)

Lead Sponsor	Collaborator
Makassed General Hospital

Country where clinical trial is conducted

Lebanon, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Pain score	Pain will measured through the Visual Analogue Scale (VAS). 0 indicates no pain and 10 indicates maximum pain	6 months